25 Jan 2013
Academic says campaign for patients raises fairness issues
A communications firm backing patients campaigning for a costly new drug has admitted it's being paid by the maker of the drug.
A communications firm backing patients campaigning for a costly new drug has admitted it's being paid by the maker of the drug.